Niagen Bioscience Inc.(NAGE:US)
Market Cap$197.85M
Key Metrics
Price$2.49
Revenue (TTM)$130.42M
Holders Revenue (TTM)$2.35M
Gross Profit (TTM)$83.83M
Earnings (TTM)$18.64M
EBITDA (TTM)$7.86M
Op. Margin (TTM)8.51%
Dividend Yield-
Holders Yield1.19%
Cash on hand$66.4M
Total Assets$114.33M
Net Assets$82.33M
Total Debt$2.58M
Key Metrics
Price$2.49
Revenue (TTM)$130.42M
Holders Revenue (TTM)$2.35M
Gross Profit (TTM)$83.83M
Earnings (TTM)$18.64M
EBITDA (TTM)$7.86M
Op. Margin (TTM)8.51%
Dividend Yield-
Holders Yield1.19%
Cash on hand$66.4M
Total Assets$114.33M
Net Assets$82.33M
Total Debt$2.58M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $31.47M | $33.84M | $33.99M | $31.12M | $30.48M | $29.13M | $25.58M | $22.74M | $22.15M |
Cost of Revenue | $11.5M | $12.14M | $12.06M | $10.89M | $11.15M | $10.93M | $9.34M | $9.05M | $8.7M |
Gross Profit | $19.98M | $21.7M | $21.93M | $20.23M | $19.33M | $18.2M | $16.24M | $13.69M | $13.46M |
| $18.4M | $19.6M | $17.69M | $17.04M | $14.56M | $11.09M | $14.64M | $13.95M | $14.19M | |
| Research and Development | $1.48M | $1.71M | $1.8M | $1.57M | $1.26M | $1.32M | $1.29M | $1.32M | $2.1M |
| Selling, General, and Administrative | $16.92M | $17.89M | $15.9M | $15.47M | $13.3M | $9.77M | $13.35M | $12.63M | $12.09M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - |
Operating Income | $1.58M | $2.1M | $4.24M | $3.19M | $4.77M | $7.11M | $1.6M | -$256K | -$731K |
| $5.16M | $552K | $564K | $552K | $459K | $373K | $276K | $241K | $239K | |
| Non-Operating Interest Income | $375K | $552K | $564K | $552K | $459K | $373K | $276K | $241K | $239K |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | $4.78M | - | - | - | - | - | - | - | - |
Income Before Tax | $6.74M | $4.42M | $4.8M | $3.74M | $5.23M | $7.48M | $1.88M | -$15K | -$492K |
Income Tax | $417K | $292K | $222K | $128K | $168K | - | - | - | - |
Net Income | $6.32M | $4.13M | $4.58M | $3.61M | $5.06M | $7.18M | $1.88M | -$15K | -$492K |
Minority Interests | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - |
Net Income to Common | $6.32M | $4.13M | $4.58M | $3.61M | $5.06M | $7.18M | $1.88M | -$15K | -$492K |
Shares Outstanding (Basic) | 79.92M | 78.97M | 79.78M | 79.25M | 77.81M | 76.95M | 75.97M | 75.56M | 75.23M |
Shares Outstanding (Diluted) | 84.57M | 84.44M | 86.62M | 86.24M | 83.23M | 81.68M | 77.77M | 75.56M | 75.23M |
EPS (Basic) | $0.08 | $0.05 | $0.06 | $0.05 | $0.07 | $0.09 | $0.02 | -$0.0002 | -$0.01 |
EPS (Diluted) | $0.07 | $0.05 | $0.05 | $0.04 | $0.06 | $0.09 | $0.02 | -$0.0002 | -$0.01 |
EBIT | $1.58M | $2.1M | $4.24M | $3.19M | $4.77M | $7.11M | $1.6M | -$256K | -$731K |
EBITDA | -$2.74M | $2.47M | $4.6M | $3.54M | $5.14M | $7.47M | $1.97M | $114K | -$341K |